CHRU Amiens
Amiens, 80054, France
Location status: Recruiting
NCT Number: NCT07030673
Among winter respiratory viruses, influenza is the most common and therefore responsible for the highest mortality, but parainfluenza and RSV viruses have an even higher risk of mortality (1.6 to 1.9 times), this toll being paid mainly by the elderly and co-morbid population. Futhermore, SARS-Cov2 will probably become endemic and/or epidemic with the same targets of fragile patients. These viral infections are serious, however a bacterial co-infection worsens the prognosis even more: excess risk of mortality = 2.6, 95% CI [1.9-3.7].
Although rare, these co-infections are the subject of a prescription of antibiotics in more than 50% of influenza infections or other serious viral infections. Mainly due to this excess risk of mortality associated with the difficulty of diagnosing these co-infections.
Proper antibiotic use requires preventing this misuse and its harmful consequences in the short and long term at all costs. It is therefore imperative to have solid (grade A) evidence showing that antibiotic therapy in viral infections is not only futile but also potentially harmful.
Interested in participating?
Request Info65 year and older
All sexes
Interventional
Not applicable
Amiens, 80054, France
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
stop antibiotics on viral or negative results
standard of care
Antibiotics are :
Amoxicilline-acide clavulanique : 1g x3/j, 7j or Ceftriaxone : 1g/j, 7j or Pipéracilline-Tazobactam : 4g x3/j, 7j or Pristinamycine : 1g x 3/j, 7j
Time frame: day 30
Time frame: day 30
Time frame: day 30
Time frame: day 180
Time frame: day 30
Length of hospitalization in acute care (days)
Contact information is provided by the study sponsor or research team.
Centre Hospitalier Universitaire, Amiens
Other
Acronym: ABUSIV
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07355192
Arterial Occlusive Diseases, Arteriosclerosis
Milwaukee, Wisconsin, United States
View Trial DetailsNCT05765656
Anxiety, Anxiety Disorders
Nantes, France
View Trial DetailsNCT04179981
Apnea, COPD
Detroit, Michigan, United States
View Trial DetailsNCT06961578
Atlanto-Axial Fusion, Elderly
Munich, Bavaria, Germany
View Trial Details